Vestal Point Capital, LP Geron Corp Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Geron Corp stock. As of the latest transaction made, Vestal Point Capital, LP holds 11,000,000 shares of GERN stock, worth $28.3 Million. This represents 2.31% of its overall portfolio holdings.
Number of Shares
11,000,000
Previous 1,050,000
947.62%
Holding current value
$28.3 Million
Previous $4.77 Billion
716.87%
% of portfolio
2.31%
Previous 0.36%
Shares
3 transactions
Others Institutions Holding GERN
# of Institutions
306Shares Held
465MCall Options Held
1.07MPut Options Held
648K-
Black Rock Inc. New York, NY46.6MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA33.5MShares$86.2 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA30MShares$77.1 Million1.72% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$70 Million18.81% of portfolio
-
State Street Corp Boston, MA27.2MShares$69.8 Million0.0% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $971M
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...